Business Wire

NEXTEK-LTD

24.3.2021 09:33:11 CET | Business Wire | Press release

Share
Nextek Reveals Global Participants in Ground-breaking Project to Tackle Post-consumer Polypropylene Packaging

Following eight years extensive research, Nextek Ltd has launched a global multi-participant project (NEXTLOOPP) to address a missing link in the plastics recycling stream - Polypropylene (PP).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210324005370/en/

PP accounts for around 20 percent of the world’s plastic.1 Mostly used in pots, tubs, trays and films for food packaging, it is also prevalent in non-food household and personal care products, which complicates recycling the 700,000 tonnes/annum used in the UK alone.2

Currently PP packaging is either going to waste-to-energy, landfill or being down-cycled into low-performance applications, wasting precious resources. Furthermore, the absence of food-grade recycled PP (FGrPP) means that all PP food packaging is currently made from virgin plastics.

Looming plastic packaging taxes have sharpened a focus on including at least 30 percent recycled content in packaging and transforming the way we manage our short-lived materials to minimise and reduce current waste levels.

NEXTLOOPP uses commercially-proven technologies to separate food-grade PP using marker technologies. These include cutting-edge decontamination stages to ensure compliance with food-grade standards in the EU and the USA. Now we can finally close the loop on FGrPP.

Major organisations including brand-owners, suppliers, universities and industry associations, through to end-users in the PP supply chain, have joined NEXTLOOPP to produce a world-first; high-quality FGrPP that will be available in the UK by 2022.

Professor Edward Kosior, founder and CEO of Nextek Ltd, explains that creating a circular economy for food-grade PP packaging waste fills the enormous gap in the packaging recycling sector and helps reach Net Zero Carbon targets. “It will allow brand owners to meet their recycling targets and significantly reduce the use of virgin plastics from petrochemicals. It will also greatly reduce CO2 emissions and divert waste from landfill and waste-to-energy.”

UK-based WRAP has confirmed that The UK Plastics Pact is pleased to support the NEXTLOOPP project in delivering a technology that will achieve food-grade polypropylene. WRAP’s Acting Director Insights and Innovation, Claire Shrewsbury, says that finding a way to successfully recycle food-contact polypropylene is a key challenge. “Achieving this will enable UK Plastics Pact members to reach the target of an average of 30 percent recycled content across all packaging by 2025. WRAP believes that NEXTLOOPP offers a potential solution to this and we will work closely with the other stakeholders to develop the project further.”

Viridor’s Director of Business Development (Polymers), Luke Burgess, says the company’s participation in the food-grade trial is in line with Viridor’s ongoing commitment to the UK circular economy. ”Viridor believes that extending its polymers expertise and recycling experience to cross-sector collaboration and innovation is key to ensuring more waste is valued as a resource and returns to the circular economy where it belongs. Reducing our reliance on virgin plastic not only empowers greater circularity, but the continued use of recycled material also offers significant energy savings, contributing to considerable wider environmental benefits for the UK.”

Lubna Edwards, Group Sustainability and Marketing Director at Robinson Packaging says: “NEXTLOOPP is absolutely aligned with Robinson’s goals and those of our customers for closed-loop solutions, as well as governmental circular economy targets. Demand for this high-value recycled material will continue to rise as we shift away from using virgin material. Much of our UK business depends upon PP and this ground-breaking project gives us the opportunity to tap into cutting-edge technology, learn from industry partners and trial the material for sustainable use in our packaging.”

Andrew Fisher, Managing Director of leading plastic packaging manufacturer Sharpak Yate, says: “As part of the Guillin Group, Sharpak has recyclability in its DNA. NEXTLOOPP is an industry-leading initiative and we are proud to be collaborating with this multi-participant project.”

Adam Elman, Group Sustainability Director at Klöckner Pentaplast says: “Capturing the value of plastics by keeping them within the economy and out of our natural environment is key to meeting the Plastics Pact targets and very much part of our business strategy. Swapping the traditional ‘take-make-waste’ linear model for a circular system is also one of the many important steps towards significantly reducing our carbon emissions. We are proud to be working in collaboration with NEXTLOOPP on this important project.”

As of 23 March 2021, 29 organisations across the PP supply chain have joined NEXTLOOPP. Other multinational companies are soon to join.

About Nextek Ltd

Nextek is a global sustainability consultancy that offers strategic advice to regional and multi-national organisations and recycling companies. Launched in 2004, Nextek researches and develops innovative strategies and processes within the recycling ecosystem – from designing recycling plants to developing ground-breaking projects for governments and major organisations. Nextek launched NEXTLOOPP, a two-year multi-participant project, to close the loop on food-grade rPP. This project incorporates unique technological breakthroughs that include innovative sorting and cutting-edge decontamination technology.

www.nextek.org

www.nextloopp.com

  1. WRAP (www.wrap.org.uk ): PlasticFlow 2025 – Plastic Packaging Flow Data Report. August 2018
  2. PlasticsEurope Market Research Group (www.plasticseurope.org/en/resources/publications/4312-plastics-facts-2020 ): AF_Plastics_the_facts-WEB-2020-ING_FINAL.PDF; Slides 23 & 25.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye